Serologicals Corporation (SERO) Agrees To Acquire LINCO Research Inc. In A $74.8 Million Deal
3/24/2006 10:58:09 AM
ATLANTA--(BUSINESS WIRE)--March 23, 2006--Serologicals Corporation (NASDAQ: SERO) announced today a definitive agreement to acquire LINCO, a privately owned life sciences company focused on supplying research assays and test kits for the Luminex-based Multiplexing platform and other immunoassays. Based in St. Louis, Missouri, LINCO consists of two companies - LINCO Research Inc. (LRI) and LINCO Diagnostic Services, Inc. (LDS). LRI is a life sciences provider of Multiplex, ELISA and RIA immunoassay products and technologies, while LDS provides bioanalytical contract services supporting research and new pharmaceutical drug development.